You should have a double by then without a buyout. They have an upcoming approval early 2018 and the best drug on the market. All they need is some decent DTC advertising and to announce a head to head trial with Linzess.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.